In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Arexis AB

Division of Biovitrum AB/Arexis AB

Latest From Arexis AB

Recent Dealmaking (9/2003)

Summarizing the month in European dealmaking.

CliniGenetics SA

French start-up CliniGenetics SA has devised an integrated pharmacogenomics and bioinformatics technology platform to identify gene and protein targets associated with vascular diseases. The company hopes to use those targets to devise novel therapies and diagnostics.
BioPharmaceutical Europe

The Battle For the Bulging

Despite disappointments in the hunt for effective fat-busting drugs, this large and seemingly ever-growing market is encouraging companies to continue to rise to the challenge of a disease that is a host of interacting disorders.
BioPharmaceutical Platform Technologies

Tackling Diabetes and Obesity

The growing incidence of these diseases, and their complexity, provide opportunities for a number of different approaches
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Biovitrum AB
  • Senior Management
  • Lennart Hansson, PhD, CEO
    Vidar Wendel-Hansen, MD, PhD, CBO
    Bjorn Lowendadler, Phd, CSO
  • Contact Info
  • Arexis AB
    Phone: (46) 317 491 100
    Arvid Wallgrens backe
    Göteborg, SE-413 46